Trilogy Capital’s Starbucks SBUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205K Sell
2,007
-280
-12% -$28.2K 0.01% 394
2026
Q1
$205K Buy
+2,287
New +$216K 0.01% 384
2022
Q1
Sell
-2,044
Closed -$239K 199
2021
Q4
$239K Buy
2,044
+7
+0.3% +$789 0.02% 157
2021
Q3
$225K Buy
2,037
+6
+0.3% +$703 0.02% 149
2021
Q2
$241K Buy
+2,031
New +$230K 0.02% 145
2018
Q4
Sell
-1,948
Closed -$111K 482
2018
Q3
$111K Sell
1,948
-203
-9% -$10.7K 0.01% 164
2018
Q2
$105K Sell
2,151
-175
-8% -$9.93K 0.01% 155
2018
Q1
$135K Buy
+2,326
New +$134K 0.02% 133

Other funds holding SBUX

Trilogy Capital's SBUX Position: Q2 2026 in Review

Trilogy Capital reduced its Starbucks (SBUX) stake by 12% in Q2 2026, selling an estimated $28.2K and leaving 2,007 shares worth $205K. The position accounts for 0.01% of the portfolio, ranked #394.

Trilogy Capital first reported a position in SBUX in Q1 2018 and has held it in 8 quarters since. The position peaked at $241K in Q2 2021. 410 funds tracked by Wall St. Rank hold SBUX as of Q2 2026.

  • Trilogy Capital held 2,007 shares of Starbucks worth $205K as of Q2 2026.
  • Trilogy Capital sold 280 Starbucks shares in Q2 2026, an estimated $28.2K.
  • Starbucks made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #394 holding.
  • Trilogy Capital first reported a position in Starbucks in Q1 2018 and has held it in 8 quarters since.
  • Trilogy Capital's Starbucks position peaked at $241K in Q2 2021.
  • 410 funds tracked by Wall St. Rank held Starbucks as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.